Smartlab Europe

Press Releases

GSK receives approval for Benlysta in Japan for the treatment of systemic lupus erythematosus

GSK announced today that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Benlysta (belimumab) for the treatment of adult patients with systemic lupus erythematosus (SLE) who are inadequate responders to existing therapies. Benlysta is for use...

Common Health Disorders in Children with Down Syndrome

Down syndrome is a genetic disorder that results in mental and physical developmental delays. In addition to these disabilities, individuals diagnosed with Down syndrome often develop certain health complications. It’s important to note that health complications...

Lonza Introduces the New CytoSMART™ 2 System for Live Cell Imaging

Lonza has introduced the CytoSMART™ 2 System, an updated version of Lonza’s popular CytoSMART™ System for live cell imaging. The CytoSMART™ 2 Device features an advanced optical system and more powerful camera unit, which enables researchers to capture higher-resolution...

Boris Johnson stresses ‘importance of the life sciences sector to the UK economy’ at TraceLink’s new European HQ launch

Foreign Secretary Boris Johnson has officially opened TraceLink’s new European headquarters in Uxbridge, UK. As the European pharmaceutical industry prepares for new serialization requirements set out in the Falsified Medicines Directive (FMD), the new headquarters will...

New In-situ Hydrolysis SPE Plates from Biotage

Biotage , a leading global supplier of solutions and technology for analytical, medicinal and peptide chemistry, is pleased to announce the launch of EVOLUTE® HYDRO, solid phase extraction plates with an integral Hydrolysis capability that enable chemists to perform...

Medical Fair Thailand Sets Record Again!

MEDICAL FAIR THAILAND 2017 concluded its most successful edition to date. It saw 830 companies from 66 countries, 18 national pavilions and country groups, and welcomed more than 9,000 quality trade visitors from over 70 countries. MEDICAL FAIR...

RedHill Biopharma Initiates Promotion of Esomeprazole Strontium Delayed-Release Capsules 49.3 mg in the U.S

RedHill Biopharma Ltd, a specialty biopharmaceutical company primarily focused on late clinical-stage development and commercialization of proprietary, orally-administered, small molecule drugs for gastrointestinal and inflammatory diseases and cancer announced that it has initiated promotion of Esomeprazole Strontium Delayed-Release (DR)...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »